At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 71 enrolled
Drug / intervention
CP-690,550 Ointment 1 +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A PHASE 2A, MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE PILOT EFFICACY, SAFETY, AND PHARMACOKINETICS OF 2 OINTMENT FORMULATIONS OF CP-690,550 IN SUBJECTS WITH MILD TO MODERATE CHRONIC PLAQUE PSORIASIS
In Brief
A Phase 2 clinical trial evaluating CP-690,550 Ointment 1, Vehicle 1, and 2 other interventions for Psoriasis. Completed, enrolled 71 participants across 12 sites in 2 countries.
Detailed Summary
The study is being conducted to see whether CP-690,550 ointment has potential as a safe and effective treatment for adult patients with mild to moderate chronic plaque psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesCanada, United States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2010
Enrollment StartFeb 2011
Primary CompletionNov 2011
TodayJul 2026
First PostedNov 23, 2010
Enrollment StartFeb 16, 2011
Primary CompletionNov 29, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.6 years ago
Interventions
CP-690,550 Ointment 1drug
2% CP-690,550 Ointment 1 twice daily for 4 weeks
Vehicle 1drug
Vehicle 1 twice daily for 4 weeks
CP-690,550 Ointment 2drug
2% CP-690,550 Ointment 2 twice daily for 4 weeks
Vehicle 2drug
Vehicle 2 twice daily for 4 weeks